Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A plus physiotherapy for post-stroke ankle spasticity
RBR-7s8qnjjPhase 3Not yet recruiting
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in Muscle spasm and stroke (2 arms), sponsored by Universidade Federal do Rio Grande do Sul. Planned start May 2022; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmstroke
Beyond the preview
Go deeper on RBR-7s8qnjj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7s8qnjj.